How to Choose a Telehealth GLP-1 Provider: A Checklist and the Red Flags

A telehealth GLP-1 provider should always have a licensed clinician review your health history before prescribing. That means a real intake that covers your weight history, other conditions, current medicines, pregnancy plans and family history, not just a quiz with a payment button at the end.

The FDA-approved labels set the basic eligibility rules. Wegovy (semaglutide) and Zepbound (tirzepatide) are approved for adults with a body mass index (BMI) of 30 or higher, or 27 or higher with at least one weight-related condition such as high blood pressure or type 2 diabetes. BMI is weight relative to height, and it is a screening tool rather than a full health picture. A good clinician looks at more than the number.

There are also safety screens. GLP-1 labels carry a boxed warning about thyroid C-cell tumors seen in rodents, so you should be asked about a personal or family history of medullary thyroid carcinoma or MEN 2 (a rare inherited endocrine syndrome). You should also be asked about pancreatitis, gallbladder disease, diabetic eye disease and pregnancy plans. If you want a deeper look at the thyroid question, see our article on [GLP-1 thyroid cancer risk](/blog/glp1-thyroid-cancer-risk-what-the-data-shows).

If a provider skips all of this and promises a prescription in minutes, treat that as a warning sign. A short, thorough intake is a good sign. No intake at all is not.

For most people, an FDA-approved medicine is the safer choice because its ingredients, doses and manufacturing are reviewed by regulators. Compounded drugs are custom versions made by a pharmacy. They are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before they are sold.

The FDA has also reported adverse events linked to dosing errors with compounded semaglutide, such as units mixed up when drawing doses from vials. That is a practical risk if you are giving yourself the injection at home. Rules about when and why compounding is allowed have shifted since the shortages ended, so the details change. Our guide to [compounded versus brand GLP-1s](/blog/compounded-vs-brand-glp1-what-changed-2026) walks through the current picture.

If a provider offers a compounded product, ask these questions: Which pharmacy makes it? Is it a licensed state pharmacy? What is the exact ingredient, strength and concentration? Is it the same active drug as the brand, or a different salt form? Will a clinician teach me how to measure the dose?

The clearest providers answer in plain language and put it in writing. Vague answers, or a refusal to name the pharmacy, are red flags.

If cost is the driver, there are other options to explore first. Direct-to-consumer pricing from manufacturers has changed fast, and we cover it in [GLP-1 direct pay pricing](/blog/glp1-direct-pay-pricing-2026-lillydirect-novocare-trumprx).

You check licensing by confirming that the clinician and the pharmacy are licensed in the right place. Start with the clinician: ask for their name and credentials, then look them up on your state medical or nursing board website. In the U.S., telehealth prescribers generally need to be licensed in the state where you live.

Next, look at the pharmacy. State boards of pharmacy license pharmacies, and the National Association of Boards of Pharmacy (NABP) runs a program that helps identify legitimate online pharmacies. A real pharmacy lists a physical address, a licensed pharmacist you can speak with, and a phone number. You should not need to take their word for it.

Be careful with products sold as "research chemicals" or "not for human use," which skip the medical system entirely. These are not made or checked for injection into people, and the FDA has warned consumers about unapproved GLP-1 products sold online.

A few other checks are simple. Look for a privacy policy that explains how your health data is used. Confirm how refills work and whether you can message a clinician. Read reviews on more than one site, and weigh the middle ones, which are often more informative than the five-star or one-star posts.

Finally, ask whether the provider will coordinate with your regular doctor. If you are on blood pressure or diabetes medicines, those may need dose changes as you lose weight.

A good price page shows the total monthly cost, not just the first-month promotion. Look for the drug and dose, the dispensing pharmacy, shipping, any membership or consultation fee, and what happens when your dose goes up. Some programs charge more at higher doses, and some change the price after an introductory period.

There are also many ways to lower cost that sit outside a telehealth company. Manufacturer savings programs, patient assistance, employer coverage and Medicare or Medicaid rules differ a lot, and eligibility can be narrow. See [patient assistance programs for GLP-1s](/blog/glp1-patient-assistance-programs-who-qualifies-2026) and [Medicare and Medicaid coverage](/blog/medicare-medicaid-glp1-coverage-2026-what-is-covered) for who qualifies. If you have a flexible spending account, check [FSA and HSA eligibility](/blog/fsa-hsa-for-glp1-what-is-eligible-2026) before you pay.

If you have employer insurance, ask HR whether weight-loss drugs are covered. Our guide on [getting your employer to cover GLP-1s](/blog/how-to-get-your-employer-to-cover-glp1-weight-loss-drugs) shows how to raise it.

Compare programs by cost per month at your likely maintenance dose, not at the starting dose. Starting doses are low on purpose, and most people move up over several months. Ask directly: "What will I pay at the highest dose I might need?"

Finally, check the cancellation and refund terms before you pay, and avoid programs that only let you cancel by phone during limited hours.

You should expect scheduled follow-up, a clear dose-increase plan, and a way to reach a clinician when side effects happen. GLP-1 medicines usually start at a low dose and step up gradually, because common side effects like nausea, constipation and diarrhea tend to be worse when doses climb quickly. In the SURMOUNT-1 trial (NEJM, 2022), gastrointestinal effects were the most common reason people stopped tirzepatide, which shows why pacing matters.

A solid program checks in at least at each dose change. It asks about side effects, hydration, protein intake, mood and any new symptoms. It also helps you decide when to hold a dose rather than push ahead. If you are struggling with symptoms, our article on [nausea on a GLP-1](/blog/nausea-on-glp1-why-it-happens-and-what-actually-helps) shows what usually helps.

Look for guidance on nutrition and muscle too. Rapid weight loss can include loss of lean mass, and a program that never mentions protein or strength training is leaving out a major piece. Our guide to [protein on a GLP-1](/blog/protein-on-glp1-how-much-you-need-to-protect-muscle) gives targets.

Finally, ask about the long game. What is the plan at your goal weight? How does the program handle maintenance, tapering or stopping? Research on stopping shows weight often returns, so a program that plans for that is more honest than one that sells only the first six months.

Women in perimenopause or menopause should ask whether the provider understands how hormones, bone and muscle interact with weight loss. Many telehealth intake forms focus on BMI alone and never ask about your cycle, hot flashes or hormone therapy.

Here are good questions to bring. Do you ask about hormone therapy, and will you coordinate with my menopause clinician? How will you help me protect muscle and bone while I lose weight? What do you do if I have sleep trouble, night sweats or mood changes? Do you screen for pregnancy risk if I am still having periods, including because GLP-1s can affect how oral birth control is absorbed with some medicines? See our article on [GLP-1s and birth control in perimenopause](/blog/glp1s-and-birth-control-in-perimenopause-what-changes).

It also helps to prepare. Bring a list of medicines, supplements and symptoms. Our guide on [talking to your doctor about GLP-1s and menopause](/blog/talking-to-your-doctor-about-glp1-and-menopause-what-to-ask) has a question list you can adapt for a telehealth visit.

If the provider cannot answer, or dismisses your menopause questions, that does not make the medicine unsafe. It may just mean you need a second clinician involved, such as a menopause-trained gynecologist or your primary care doctor.

Choosing a provider is easier when you know what you need. Lea can help you compare your options, prepare your questions, and understand what to expect at each stage.